The therapeutic effect of PD-1–laIL-2 was totally abolished in Rag1–/– mice (Figure 3A), which suggests that NK cells are not sufficient for PD-1–laIL-2–induced tumor control and that T cells are required for the therapeutic function of PD-1–laIL-2. The gene discussed is RAG1; the disease is neoplasm.